Cargando…

Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation

BACKGROUND: End-stage renal disease patients have a dysfunctional, prematurely aged peripheral T-cell system. Here we hypothesized that the degree of premature T-cell ageing before kidney transplantation predicts the risk for early acute allograft rejection (EAR). METHODS: 222 living donor kidney tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dedeoglu, Burç, Meijers, Ruud W. J., Klepper, Mariska, Hesselink, Dennis A., Baan, Carla C., Litjens, Nicolle H. R., Betjes, Michiel G. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780739/ https://www.ncbi.nlm.nih.gov/pubmed/26950734 http://dx.doi.org/10.1371/journal.pone.0150826

Ejemplares similares

T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation
por: Dedeoglu, Burç, et al.
Publicado: (2017)

The FCGR3A 158 V/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection
por: Litjens, Nicolle, et al.
Publicado: (2021)

Polyfunctional donor-reactive T cells are associated with acute T-cell-mediated rejection of the kidney transplant
por: Litjens, Nicolle H R, et al.
Publicado: (2023)

High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
por: Litjens, Nicolle H. R., et al.
Publicado: (2017)

End-Stage Renal Disease Causes Skewing in the TCR Vβ-Repertoire Primarily within CD8(+) T Cell Subsets
por: Huang, Ling, et al.
Publicado: (2017)

pERK-dependent defective TCR-mediated activation of CD4(+) T cells in end-stage renal disease patients
por: Huang, Ling, et al.
Publicado: (2017)

A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness
por: Bouvy, Anne P., et al.
Publicado: (2016)

Expression of Senescence Marker TIGIT Identifies Polyfunctional Donor-Reactive CD4+ T Cells Preferentially Lost After Kidney Transplantation
por: van der List, Amy C. J., et al.
Publicado: (2021)

A Novel Technique for the Generation of Substantial Numbers of Functional Resident T Cells from Kidney Tissue
por: Betjes, Michiel G. H., et al.
Publicado: (2022)

Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
por: Betjes, Michiel G. H., et al.
Publicado: (2013)

End stage renal disease patients have a skewed T cell receptor Vβ repertoire
por: Huang, Ling, et al.
Publicado: (2015)

Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients
por: Meijers, Ruud WJ, et al.
Publicado: (2012)

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
por: Boer, Karin, et al.
Publicado: (2016)

Single-Cell RNA Sequencing of Donor-Reactive T Cells Reveals Role of Apoptosis in Donor-Specific Hyporesponsiveness of Kidney Transplant Recipients
por: van der List, Amy C. J., et al.
Publicado: (2023)

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection
por: van Besouw, Nicole M., et al.
Publicado: (2019)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets
por: Litjens, Nicolle HR, et al.
Publicado: (2011)

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2019)

Validation of a Combined Transcriptome and T Cell Receptor Alpha/Beta (TRA/TRB) Repertoire Assay at the Single Cell Level for Paucicellular Samples
por: Litjens, Nicolle H. R., et al.
Publicado: (2020)

Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: de Graav, Gretchen N., et al.
Publicado: (2017)

Activated CD4(+) T Cells and Highly Differentiated Alloreactive CD4(+) T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients
por: Duizendstra, Aafke A., et al.
Publicado: (2021)

Current Tolerance-Associated Peripheral Blood Gene Expression Profiles After Liver Transplantation Are Influenced by Immunosuppressive Drugs and Prior Cytomegalovirus Infection
por: Duizendstra, Aafke A., et al.
Publicado: (2022)

High cut-off haemodialysis induces remission of recurrent idiopathic focal segmental glomerulosclerosis after renal transplantation but is no alternative to plasmapheresis
por: Noorlander, Iris, et al.
Publicado: (2011)

Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells
por: de Graav, Gretchen N., et al.
Publicado: (2016)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
por: Sablik, Kasia A., et al.
Publicado: (2020)

The number of donor HLA-derived T cell epitopes available for indirect antigen presentation determines the risk for vascular rejection after kidney transplantation
por: Betjes, Michiel G. H., et al.
Publicado: (2022)

Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2021)

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
por: Hurkmans, Daan P., et al.
Publicado: (2019)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Effects of Morbid Obesity and Metabolic Syndrome on the Composition of Circulating Immune Subsets
por: Wijngaarden, Leontine H., et al.
Publicado: (2021)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023)

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection
por: Hullegie‐Peelen, Daphne M., et al.
Publicado: (2022)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation
por: Peters, Fleur S., et al.
Publicado: (2017)

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
por: van der Zwan, Marieke, et al.
Publicado: (2018)

CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
por: Silva, Marcos V., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qu3m0n54ub040j1thr48uegr7h